Cloud & Digital Solutions Adoption in Biopharma – Report 2022
How will life science companies harness cloud & digital solutions in 2022?
The continued drive for innovation and cost efficiency puts high pressure on the life science sector – especially the IT and R&D departments. While the average production costs of a biologic drug beat $22/day, biotech & pharma companies have to develop new digital solutions at speed and, of course, with regulatory challenges in mind.
Cloud Adoption Report 2022
We decided to explore the cloud & digital solution market and find out what awaits the bio-pharma IT departments in 2022.
In the report, you will find:
- Cloud adoption dynamics
- Opportunities and risks for bio-pharma companies
- List of top digital tools in biopharma manufacturing
Click the image below and download the report
